Search Results 281-290 of 16110 for GLP-1 agonist

  1. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

    The purpose of this study is to monitor T cell responses from patients with advanced cancer who are being treated with an anti-PD (programmed death)-1 ...

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest ...

  3. Spironolactone (oral route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Digitoxin; Gossypol; Licorice ...

  4. Lisinopril (oral route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. ... You may report side effects to ...

  5. Endocrinology - Clinical trials

    ... agonist pioglitazone, with or without weight loss ... The purpose of this study is to evaluate whether or not a 6 month supply (1 ... Go to page 11 · Go to page 22 ...

  6. Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) - Mayo Clinic

    Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled ...

  7. A Study of the Effectiveness and Safety of Subcutaneous Semaglutide for Patients with Fatty-Liver Disease, not Caused by Alcoholism - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

  8. A Study of Individualized Obesity Pharmacotherapy Based on Obesity Phenotypes - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

  9. Varicose veins - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the ... Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri ...

  10. Publications - Ty S. Diwan, M.D. - Mayo Clinic

    Benefits of Glucagon-like Peptide-1 Receptor Agonists After Kidney Transplantation. Endocr Pract. 2025 Mar 5 Epub 2025 Mar 05. View PubMed; Long JJ, Sahi SS ...